1585969-26-1 Usage
Uses
Used in Organic Synthesis:
(2S,2'S)-di-tert-butyl 2,2'-(5,5'-((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-1-carboxylate) 4-nitrobenzoic acid is used as a building block for the synthesis of more complex organic molecules due to its diverse functional groups.
Used in Pharmaceutical Industry:
(2S,2'S)-di-tert-butyl 2,2'-(5,5'-((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-1-carboxylate) 4-nitrobenzoic acid is used as a potential drug candidate for the development of new therapeutic agents, given its unique structure and functional groups.
Used in Materials Science:
(2S,2'S)-di-tert-butyl 2,2'-(5,5'-((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-1-carboxylate) 4-nitrobenzoic acid is used as a component in the development of new materials with specific properties, such as polymers or coatings, due to its versatile functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 1585969-26-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,8,5,9,6 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1585969-26:
(9*1)+(8*5)+(7*8)+(6*5)+(5*9)+(4*6)+(3*9)+(2*2)+(1*6)=241
241 % 10 = 1
So 1585969-26-1 is a valid CAS Registry Number.
1585969-26-1Relevant articles and documents
PROCESS FOR PREPARING TETRACYCLIC HETEROCYCLE COMPOUNDS
-
, (2015/05/19)
The present invention is directed to a process for preparing Tetracyclic Heterocycle Compounds of formula (I): which are useful as HCV NS5A inhibitors. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
Enantioselective synthesis of an HCV NS5a antagonist
Mangion, Ian K.,Chen, Cheng-Yi,Li, Hongmei,Maligres, Peter,Chen, Yonggang,Christensen, Melodie,Cohen, Ryan,Jeon, Ingyu,Klapars, Artis,Krska, Shane,Nguyen, Hoa,Reamer, Robert A.,Sherry, Benjamin D.,Zavialov, Ilia
, p. 2310 - 2313 (2014/05/20)
A concise, enantioselective synthesis of the HCV NS5a inhibitor MK-8742 (1) is reported. The features of the synthesis include a highly enantioselective transfer hydrogenation of an NH imine and a dynamic diastereoselective transformation. The synthesis of this complex target requires simple starting materials and nine linear steps for completion.
